Header Logo

Connection

RANJAN BISTA to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications RANJAN BISTA has written about Antineoplastic Agents.
RANJAN BISTA
Connection Strength
0.096
Antineoplastic Agents
  1. Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to First and Second Generation ROS1 Inhibitors. J Pediatr Hematol Oncol. 2021 07 01; 43(5):e718-e722.
    View in: PubMed
    Score: 0.096
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.